- MyIllumina
- Tools
Featuring highly polymorphic SNP content and providing uniform genomic coverage, the CanineHD BeadChip enables the interrogation of genetic variation in any domestic dog breed. Importantly, this BeadChip presents an average of greater than 70 markers per megabase (Mb), providing ample SNP density for robust within-breed association and copy number variation (CNV) studies.
This BeadChip contains more than 170,000 markers placed on the CanFam2.0 reference sequence. Illumina developed the BeadChip in collaboration with the LUPA Consortium, which includes 22 European universities and other partners such as the Broad Institute.
Catalog IDs: WG-440-1001, WG-440-1002, WG-440-1003
Product Literature
| CanineHD Data Sheet |
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.